Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Osteosarcoma × apatinib × Clear all

Phase

Status

Unknown 4 Completed 3 Suspended 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Osteosarcoma 1 Drug-Related Side Effects and Adverse Reactions 1 Colorectal Neoplasms 1

Interventions

Specimen Handling 2 trastuzumab deruxtecan 1 fludarabine phosphate 1 apatinib 1 X-Rays 1 Cyclophosphamide 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04824352 2024-05-14

AIEO

Peking University People's Hospital

Phase 2 Suspended

Osteosarcoma, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon ⚡